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Abstract
Aims
Combining mesenchymal stem cells (MSCs) and chondrocytes has great potential for cell-
based cartilage repair. However, there is much debate regarding the mechanisms behind
this concept. We aimed to clarify the mechanisms that lead to chondrogenesis (chondrocyte
driven MSC-differentiation versus MSC driven chondroinduction) and whether their effect
was dependent on MSC-origin. Therefore, chondrogenesis of human adipose-tissue-
derived MSCs (hAMSCs) and bone-marrow-derived MSCs (hBMSCs) combined with
bovine articular chondrocytes (bACs) was compared.
Methods
hAMSCs or hBMSCs were combined with bACs in alginate and cultured in vitro or implanted
subcutaneously in mice. Cartilage formation was evaluated with biochemical, histological
and biomechanical analyses. To further investigate the interactions between bACs and
hMSCs, (1) co-culture, (2) pellet, (3) Transwell® and (4) conditioned media studies were
conducted.
Results
The presence of hMSCs–either hAMSCs or hBMSCs—increased chondrogenesis in cul-
ture; deposition of GAG was most evidently enhanced in hBMSC/bACs. This effect was sim-
ilar when hMSCs and bAC were combined in pellet culture, in alginate culture or when
conditioned media of hMSCs were used on bAC. Species-specific gene-expression analy-
ses demonstrated that aggrecan was expressed by bACs only, indicating a predominantly
trophic role for hMSCs. Collagen-10-gene expression of bACs was not affected by
hBMSCs, but slightly enhanced by hAMSCs. After in-vivo implantation, hAMSC/bACs and
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hBMSC/bACs had similar cartilage matrix production, both appeared stable and did not
calcify.
Conclusions
This study demonstrates that replacing 80% of bACs by either hAMSCs or hBMSCs does
not influence cartilage matrix production or stability. The remaining chondrocytes produce
more matrix due to trophic factors produced by hMSCs.
Introduction
Cartilage has a very limited capacity for self-regeneration. Untreated lesions—caused by
trauma, tumors, congenital malformation or age related degeneration—persist indefinitely
and ultimately require surgical intervention. However, current treatments are unsuccessful for
long-term repair; resulting in a need for novel repair strategies. Cell-based cartilage repair
holds promise for restoring missing or destroyed cartilage and has the potential to overcome
limitations of current treatments, while re-establishing the unique biological and functional
properties of the tissue.
One of the major challenges herein is defining an appropriate cell source. Current cell-
based surgical treatments for cartilage lesions are predominantly based on the use of either
(1) chondrocytes or (2) mesenchymal stem cells (MSCs). These cell-based procedures are how-
ever associated with specific disadvantages. Chondrocytes from several anatomical locations
(e.g. joint, rib, nose, ear, meniscus) have been investigated for their application in cartilage
regeneration. [1–21] However, to generate a construct of reasonable size, large numbers of
chondrocytes are required, necessitating the use of culture-expansion. In monolayer culture-
expansion, chondrocytes dedifferentiate; they change phenotypically to a fibroblast-like mor-
phology and lose their chondrogenic gene-expression capacity. Chondrocyte-dedifferentiation
usually results in fibrous and mechanically inferior cartilage, making them less suitable for
cell-based cartilage repair. [22] In contrast, multipotent cells, like MSCs, achieved considerable
attention as alternative cells, as they can undergo multiple population doublings without losing
their chondrogenic potential and have the capacity to differentiate into cartilage tissue under
appropriate culture conditions. [23–27] Furthermore, MSCs are easily available from several
tissues, including bone marrow and adipose tissue, which makes culture-expansion unneces-
sary. However, the single use of MSCs for cell-based cartilage repair is currently debated, since
the cartilage tissue formed is unstable and predisposed to mineralization and ossification in
vivo. [28–32]
Currently, combining both cell sources holds great promise for cell-based cartilage repair as
it reduces the required number of chondrocytes and diminishes many disadvantages of both
individual cell types. Moreover, by decreasing the amount of chondrocytes required ( 20% of
the total cell mixture), culture-expansion is no longer necessary, which would allow the use of
freshly isolated primary chondrocytes leading to improved cartilage formation. [33] Unfortu-
nately, in depth understanding of the cellular interaction pathways between MSCs and chon-
drocytes is under debate in literature: It is thought that the co-culture effect is either credited
by (1) chondrocyte driven MSC-differentiation or ascribed to (2) chondrocytes, whose carti-
lage-forming capacity and proliferation activity are enhanced in the presence of MSCs. [34] In
recent years, the trophic and paracrine functions of MSCs appeared most critical in this pro-
cess, rather than the simple chondrogenic differentiation of MSCs alone. However, little is
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known as to whether their trophic function is a general characteristic of MSCs or dependent
on the origin of the MSC source. MSCs from several anatomical locations have been applied in
co-culture. Independent on their origin, mixed cell cultures of chondrocytes and MSCs have been
demonstrated to generally improve chondrogenesis as well as to reduce hypertrophy and tissue
mineralization. [34–36] In contrast, three co-culture studies using adipose-tissue-derived MSCs
(AMSCs) showed limited or decreased effects of MSCs on chondrogenesis. [37–39] Such effect
was hardly seen in co-culture studies using bone-marrow-derived MSCs (BMSCs), which may
propose that, compared to BMSCs, AMSCs are less efficient in co-culture. Due to methodological
heterogeneity however, a direct comparable analysis between AMSCs and BMSCs in co-culture
could not be easily made. So far, only three research groups have directly compared the effect of
AMSCs and BMSCs on chondrocytes in co-culture. [40–42] Unfortunately, these studies demon-
strate conflicting outcomes and have never translated to animal research.
Therefore, we aim to investigate whether MSCs undergo chondrogenic differentiation
upon contact with chondrocytes or by trophic effects of MSCs on chondrocytes. Whether the
co-culture effect is dependent on MSC-origin or a general characteristic of MSCs, is further
elucidated. Therefore, chondrogenesis of human AMSCs (hAMSCs) and BMSCs (hBMSCs)
combined with bovine articular chondrocytes (bACs) is compared. The xenogeneic set-up
using hMSCs and bACs will allow conclusions about the cell type responsible for chondrogen-
esis. As cellular interactions can be influenced or overruled by exogenous growth factors, no
growth factors are added to the culture system to study cartilage formation of the co-cultures
in vitro. Moreover, cartilage formation will be evaluated after immediate subcutaneous
implantation of the constructs in mice. To further elucidate the interactions between MSCs
and ACs, different in-vitro culture systems will be used: (1) co-culture system of hMSC/bACs
in alginate, (2) pellet co-culture system of hMSC/bACs, (3) Transwell1 system of singular iso-
lated hMSCs and bACs in alginate, and (4) conditioned media culture systems of conditioned
medium of hMSCs on bACs and vice versa.
Materials and methods
Chemicals were obtained from Sigma-Aldrich, USA unless stated otherwise.
Cell sources
All human samples were obtained after approval by the Erasmus MC Medical Ethical Committee.
Human mesenchymal stem cells (hMSCs) were isolated from either adipose tissue (hAMSCs) or
bone-marrow aspirates (hBMSCs). hAMSCs were obtained from subcutaneous abdominal adi-
pose tissue as waste material without the need for informed consent (protocol # MEC-2011-371)
(n = 3 independent donors: F 52Y; F 51Y; F 53Y). hBMSCs were isolated from bone-marrow hepa-
rinized aspirates, after written informed consent had been acquired (protocol # MEC-2004-142
and Albert Schweitzer Hospital 2011/7) (n = 3 independent donors: M 67Y; F 75Y; M 22Y). Both
hAMSCs and hBMSCs were seeded and cultured overnight in medium consisting of Minimum
Essential Medium Alpha (MEM-α; Gibco, USA), supplemented with 10% fetal calf serum (FCS;
Lonza, the Netherlands), 10−4 M L-ascorbic acid 2-phosphate, and 1 ng/mL basic Fibroblast
Growth Factor 2 (bFGF2; AbD Serotec, UK). [43–45]
Articular chondrocytes (ACs) were selected, to study the trophic effect of hAMSCs or
hBMSCs on chondrocytes. To obtain primary bovine articular chondrocytes (bACs), macro-
scopically intact cartilage was harvested from the metatarsophalangeal joints of calves 6
months old (T. Boer & Zn., Nieuwerkerk aan den IJssel, the Netherlands), and washed with
saline (n = 4 pools of 3 donors each). To isolate cells, cartilage pieces were incubated for 1 hour
with 2 mg/mL protease (type XIV derived from Streptomyces griseus), followed by overnight
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incubation with 1.5 mg/mL collagenase B (Roch Diagnostics, Germany) in High Glucose—
Dulbecco’s Modified Eagle’s Medium (HG-DMEM; Gibco) with 10% FCS, 50 μg/mL gentamy-
cin (Gibco), and 0.5 μg/mL amphotericin B (Fungizone; Life Technologies, Breda, the Nether-
lands). To extract small parts of undigested cartilage, the cell suspension was filtered through a
nylon 100-μm mesh. Prior to cell culture, cell viability was tested using the trypan blue exclu-
sion test, and cell number was calculated with a hemocytometer.
Chondrogenesis
For in-vitro and in-vivo studies, all cells were encapsulated in alginate (Batch MG-004,
CellMed, Germany), a hydrogel known of its high biocompatibility [46] and chondrogenic
capacity [47]. Moreover, alginate hydrogels enable homogeneous cell distribution and allow
paracrine factors to access all cells equally [47], making them suitable scaffolds for following
research purposes.
Second-passaged hMSCs and non-expanded primary bACs were harvested and cultured in
a 3D-alginate hydrogel. Cells were suspended at a density of 4x106 cells/mL in clinical grade
1.1% low viscosity alginate solution dissolved in 0.9% NaCl as single-cell-type populations or
as a combination of 80% hMSCs (either hAMSCs or hBMSCs) and 20% bACs. (Table 1) A 4:1
ratio was selected based on our previous experience [48] and that of others [49, 50].
Flat constructs (8 mm diameter; 2 mm height) were processed as previously described. [2]
In short, alginate suspensions were injected into a custom designed slab mold consisting of 2
calcium-permeable membranes (Durapore1 5.0 μm membrane filters, Millipore) rigidly sup-
ported by stainless-steel meshes and separated by a stainless-steel casting frame. Alginate was
instantaneously gelated for 30 minutes in 102 mM CaCl2 and thereafter washed with 0.9%
NaCl and HG-DMEM. Sterile biopsy punches (Spengler, Asnières sur Seine, France) were
used to create alginate constructs suitable for mechanical testing. Constructs were either cul-
tured in vitro or directly implanted subcutaneously in mice. (Fig 1A)
In vitro, constructs were cultured in ‘basic medium’ containing serum-free HG-DMEM
supplemented with 50 μg/mL gentamycin; 0.5 μg/mL Fungizone; 1 mM sodium pyruvate
(Gibco); 40 μg/mL L-proline; supplemented Insulin Transferrine Selenium (ITS+; B&D Bio-
science, Bedford, MA, USA); 10−7 M dexamethason; and 25 μg/mL L-ascorbic acid 2-phos-
phate without the addition of growth factors. For each condition referred to in Table 1, 3
independent donors were used in triplicate (total n = 54). After 3 and 5 weeks, constructs were
processed for biochemical and gene-expression analysis.
In-vivo studies were completed after 8 weeks of subcutaneous implantation. In total, 10
9-week-old, female NMRI nu/nu mice (Charles River Laboratories, the Netherlands) were
Table 1. Construct conditions.
Human stem cells Bovine chondrocytes
Source Cell density (x106) Source Cell density (x106)
hAMSC hAMSCs 4 nc/mL x x
hBMSC hBMSCs 4 nc/mL x x
bAC x x bACs 4 nc/mL
hAMSC/bAC hAMSCs 3.2 nc/mL bACs 0.8 nc/mL
hBMSC/bAC hBMSCs 3.2 nc/mL bACs 0.8 nc/mL
Control bAC x x bACs 0.8 nc/mL
Cell density is displayed as the number of cells (nc) in 1 milliliter of alginate. hAMSC = human Adipose-tissue-derived Mesenchymal Stem Cell; hBMSC = human Bone-
marrow-derived Mesenchymal Stem Cell; bAC = bovine Articular Chondrocyte.
https://doi.org/10.1371/journal.pone.0190744.t001
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used. Two separate incisions were made along the central line of the spine (1 at the shoulders
and 1 at the hips), after which 4 separate subcutaneous dorsal pockets were prepared by blunt
dissection. For each condition referred to in Table 1, 3 independent donors were used in dupli-
cate (total n = 36). Moreover, cell-free constructs were used as controls (n = 4). For implanta-
tion, alginate constructs were randomly assigned to these 4 pockets. After 8 weeks, animals
were sacrificed and samples were explanted for histological, biomechanical and biochemical
analyses. Animal experiments were carried out to the guidelines prescribed by the Dutch
National Institutes of Health, and were approved by the Dutch equivalent of the Institutional
Animal Care and Use Committee, the Erasmus MC Dier Ethische Commissie (protocol #
EMC 2429).
Cellular interaction
To further understand the complex cellular communication pathways between MSCs and
ACs, cell types (hAMSCs (F 53Y); hBMSCs (M 22Y); bACs pool of 3 donors) were co-cultured
as follows: (1) hMSCs and bACs were combined and cultured in alginate as previously
described; (2) hMSCs and bACs were cultured in pellets, allowing direct cell-cell contact. Fur-
thermore, hMSCs and bACs were encapsulated in alginate separately and co-cultured in (3) a
Fig 1. Cellular interaction. Cells were encapsulated in alginate beads separately and alginate and pellet co-cultures (A, control conditions). Furthermore,
hMSCs and bACs were co-cultured in (B) a Transwell1 system as well as in (C) medium conditioned by the other cell type, to further understand the
complex cellular communication pathways between hMSCs and bACs. In purple: hMSCs = human Mesenchymal Stem Cells; in green: bACs = bovine
Articular Chondrocytes.
https://doi.org/10.1371/journal.pone.0190744.g001
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Transwell1 system; as well as (4) in medium conditioned by the other cell type. (Fig 1) The
ratio of hMSCs to bACs in each culture system was kept 80:20 for all conditions. All constructs
were cultured under standardized nutritional conditions. Medium was changed 3 times a
week. After 3 weeks, alginate beads and pellets were processed for biochemical or gene-expres-
sion analysis.
(1) Co-culture. hMSCs and bACs were suspended at a density of 4x106 cells/mL in clinical
grade alginate solution as a mixed-cell-type population at a 80:20 ratio as described above.
(Fig 1A)
(2) Pellet culture. To study the effects of direct cell-cell contact in co-cultures, hMSCs
and bACs were cultured in pellets. Therefore, a mixture of 80% hMSCs and 20% bACs was sus-
pended in basic medium and a total number of 2,5x105 cells in 0.5 mL were transferred into
polypropylene tubes and pellet were formed by centrifuging at 200 G for 8 minutes. To induce
proper pellet formation, addition of Transforming Growth Factor β1 (TGFβ1; R&D Systems,
USA) for 24 hours was required. This exposure was not sufficient to induce chondrogenesis in
hMSCs (data not shown). After 24 hours, pellet were exposed to the ‘basis medium’ without
addition of any growth factors. (Fig 1A)
(3) Transwell1 system. hMSCs and bACs were suspended at a density of 4x106 cells/mL
in clinical grade alginate solution as single-cell-type populations and transferred into a 10-mL
sterile syringe. Thereafter, the cell-suspension was slowly passed through a 23-gauge needle to
produce drops, which fell into a 102 mM CaCl2 creating alginate beads. Following instanta-
neous gelation, beads were allowed to further gelate for a period of 10 minutes in the CaCl2-
solution. After being washed once with 0.9% NaCl and HG-DMEM, the beads were trans-
ferred to a Transwell1 system (Corning Life Science, USA). The Transwell1 inserts sepa-
rated hMSCs and bACs by a porous membrane of 8 μm, allowing paracrine signaling between
hMSCs and bACs. (Fig 1B)
(4) Conditioned medium. Alginate beads containing hMSCs or bACs were produced as
described above and cultured in medium conditioned by the other cell types. To obtain bACs,
hAMSCs and hBMSCs conditioned media, alginate beads were cultured in ‘basic medium’ for
3 days. After 3 days of culture, conditioned media were collected, enriched with 1:1 ‘basic
medium’ and immediately added to alginate cultures of the other cell types. Again, a 80:20
ratio between hMSCs and bACs was maintained. (Fig 1C)
Biochemical evaluation of the extracellular matrix
Alginate constructs were digested overnight at 56˚C in papain (250 μg/mL in 0.2 M
NaH2PO4, 0.01 M EDTA, containing 5 mM L-cystein; pH 6.0); pellets were digested overnight
at 56˚C in proteinase K (1 mg/mL in Tris/EDTA buffer containing 185 μg/mL iodoacetamide
and 1 μg/mL pepstatin A; pH 7.6). After digestion, samples were subjected to biochemical
analyses to determine DNA, glycosaminoglycan (GAG), and hydroxyproline contents as
described previously. [2] In short, the amount of DNA was determined by Ethidium bromide
(GibcoBR1), using calf thymus DNA as a standard. Sulphated GAGs were quantified by the
1,9-Dimethylmethylene blue (DMMB) dye-binding assay, using shark chondroitin sulphate C
as a standard. To be suitable for cell cultures containing alginate, the DMMB-pH-level was
adjusted to pH 1.75, as described previously. [51] For the hydroxyproline content, digests were
hydrolysed, dried and redissolved in 150 μL water. Hydroxyproline contents were measured
using chloramine-T and dimethylaminobenzaldehyde as reagents and hydroxyproline (Merck,
Germany) as a standard. Collagen content was subsequently estimated from the hydroxypro-
line content, assuming that one collagen triple helix molecule contains 300 hydroxyproline
residues.
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Histological evaluation
After 8 weeks of subcutaneous implantation, constructs were harvested, set in 2% agarose,
fixed in 4% formalin in PBS and embedded in paraffin. Paraffin-embedded sections (6 μm)
were deparaffinised and rehydrated.
To evaluate tissue calcification, Von Kossa staining was performed. Slides were immersed
in 5% silver nitrate solution for 10 minutes, rinsed in MilliQ and exposed to light for another
10 minutes. Excess silver nitrate was removed with 5% sodium-thiosulphate and slides were
rinsed in distilled water afterwards. Sections were counterstained with Nuclear fast red
(Merck).
To examine proteoglycans present in the newly synthesized ECM, deparaffinised sections
were stained with Safranin-O and fast green.
To allow the use of monoclonal mouse antibody collagen type II (II-II6B3 1:100; Develop-
mental Studies Hybridoma Bank, USA) on constructs which had been implanted in mice, the
primary antibody was pre-coupled overnight with goat anti-mouse biotin at 4˚C (1:500; Jack-
son Laboratories, USA), followed by a 2-hour incubation in 0.1% normal mouse serum (CLB,
the Netherlands), to prevent unwanted binding of the anti-mouse antibodies to mouse immu-
noglobulins. [52] Antigen retrieval was performed through incubation with 0.1% pronase for
30 minutes at 37˚C, continued with a 30 minutes incubation with 1% hyaluronidase at 37˚C.
Non-specific binding sites were blocked with 10% goat serum and sections were stained with
the pre-treated antibodies for 60 minutes. Sections were than incubated with enzyme-strepta-
vidin conjugate (Label, 1:100, Biogenex, HK-321-UK, USA) in PBS/1% BSA, followed by incu-
bation with Neu Fuchsin substrate (Chroma, Germany).
Biomechanical analysis
In order to distinguish the mechanical strength of alginate itself, cell containing constructs
were prepared and directly taken for mechanical testing as described previously. [2] In short,
for mechanical characterization of engineered cartilage constructs after in vivo cell culture,
constructs 2.5 mm thick and 5 mm in diameter were used. The samples were placed in close-
fitting Ø 5 mm stainless steel cylindrical wells. Mechanical testing was performed with a mate-
rials testing machine (Zwick Z005, Ulm, Germany) equipped with a 10 N load cell, a built-in
displacement control, and a cylindrical, plane ended, stainless steel indenter (Ø 1.2 mm). Dur-
ing mechanical testing the samples were immersed in PBS. Stress-strain testing was performed:
the samples were compressed to a final height of 0.5 mm at a loading rate of 5 mm per minute.
An in-house Matlab1 script was used to locate the sample surface and measure the sample
thickness. Force-displacement curves were then converted to stress-strain curves. Measure-
ments of compressive modulus at 40% strain, E40%, were determined for every sample.
Gene-expression analyses
For total RNA isolation, alginate was dissolved in ice-cold 55 mM sodium citrate and 20 mM
Ethylene Diamintetraacetate (EDTA) in 150 mM NaCl and centrifuged. Each cell-pellet was
subsequently suspended in 1 mL RNA-BeeTM (TEL-TEST, USA). For total RNA isolation
from pellets, pellets were manually homogenized and suspended in 300 μL/pellet RNA-BeeTM.
RNA was extracted with chloroform and purified from the supernatant using the RNAeasy
Micro Kit (Qiagen, Germany) according to the manufacturer’s guidelines by on-column
DNA-digestion. Extracted total RNA was quantified using NanoDrop1 ND-1000 Spectro-
photometer (NanoDrop Technologies, Wilmington, DE, USA) at 260/280 nm. Total RNA of
each sample was reverse transcribed into cDNA using RevertAidTM First Strand cDNA Syn-
thesis Kit (MBI Fermentas, Germany).
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For quantitative real-time Polymerase Chain Reaction (qRT-PCR) analysis, forward and
reverse primers were designed using PrimerExpress 2.0 software (Applied Biosystems, USA)
to meet TaqMan or SYBR Green requirements. Gene specificity of all primers was guaranteed
by Basic Local Alignment Search Tool (BLASTN). Analysed genes are listed in Table 2. qRT-
PCR was performed using qPCR Mastermix Plus for SYBR Green (Eurogentec, the Nether-
lands) according to the manufacturers’ guidelines and using ABIPRISM1 7000 with SDS soft-
ware version 1.7 (Applied Biosystems, the Netherlands). Relative gene expressions were
calculated by means of the 2-ΔCT formula.
Statistical analysis
All data were analyzed with PSAW statistics 20.0 (SPSS inc. Chicago, USA). For in vitro algi-
nate co-cultures, the mean and standard deviation represents at least three independent
donors per cell source performed in triplicate. For statistical evaluation, a mixed linear model
was used followed by a Bonferroni’s post-hoc comparisons test. Condition and time point
were defined as fixed factors in the model. Donor and sample number were treated as random
factors. For in vivo alginate co-cultures, the mean and standard deviation represents at least
three independent donors per cell source performed in duplicate. For the evaluation of the cel-
lular communication pathways between MSCs and ACs, the mean and standard deviation rep-
resents one donor per cell source performed in sextuple. For statistical evaluation, the Kruskal-
Wallis followed by the Mann-Whitney-U tests was used followed by a Bonferroni’s post-hoc
comparisons test. For all tests, values of p<0.05 were considered statistically significant.
Results
Cartilage regeneration in co-cultures
In vitro outcomes. After 3 weeks, DNA content of alginate constructs containing either
co-cultures of hMSCs and bACs or single-cell-type populations, did not change in relation
to their initial DNA content. (Fig 2A) Because the amount of DNA had not changed signifi-
cantly in any of the conditions, matrix deposition was expressed per construct and per initially
Table 2. Sequences of primers for qRT-PCR.
Primers and probes
Human specific genes
hsGAPDH Fw: AGCTCACTGGCATGGCCTTC
Rev: CGCCTGCTTCACCACCTTCT
hsACAN Fw: CAGCCACCACCTACAAACGCAG
Rev: CTGGGTGGGATGCACGTCAGC
hsCOL2A1 Fw: ACGAGGCCTGACAGGTCCCA
Rev: GCCCAGCAAATCCCGCTGGT
Bovine specific genes
bsGAPDH Fw: GTCAACGGATTTGGTCGTATTGGG
Rev: TGCCATGGGTGGAATCATATTGG
bsACAN Fw: GGACACTCCTTGCAATTTGAGAA
Rev: CAGGGCATTGATCTCGTATCG
COL2A1 Fw: GGCAATAGCAGGTTCACGTACA
Rev: CGATAACAGTCTTGCCCCACTT
GAPDH = GlycerAldehyde 3-Phosphate DeHydrogenase; ACAN = Aggrecan; COL2A1 = Collagen type 2; hs = human-specific; bs = bovine-specific.
https://doi.org/10.1371/journal.pone.0190744.t002
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seeded primary ACs. After 5 weeks, DNA content did significantly decrease in constructs con-
taining hBMSCs only (p<0.001), but remained unchanged in the remaining culture condi-
tions. (S1 Fig)
Since constructs were cultured in the absence of chondrogenic factors, constructs containing
solely hAMSCs or hBMSCs produced very little GAG (Fig 2B) and collagen (Fig 2C). To demon-
strate the additional effect of hMSCs in mixed-cell-type populations, a control condition—con-
taining similar numbers of bACs (0.8106 nc/mL) without the supplementation of hMSCs—was
evaluated (Fig 2 dotted lines). The addition of either hAMSCs or hBMSCs to bACs demonstrated
a significant increase in the production of GAG over their controls (hAMSC/bACs p = 0.018;
hBMSC/bACs p<0.001). Compared to constructs containing single-cell-type populations, the
deposition of GAG was most evidently enhanced in co-cultures combining hBMSCs and bACs
(p<0.001). Constructs containing hAMSC/bACs deposited significantly less GAG compared to
hBMSC/bACs (p<0.001) and equal amounts compared to constructs containing bACs only. (Fig
Fig 2. Cartilage matrix formation in constructs containing hMSCs and/or bACs, 3 weeks after in-vitro culture. (A) The DNA content of none of the
constructs had changed compared to their initial DNA content prior to cell-culture (dotted line). Biochemical evaluation of the GAG (B) and collagen (C)
content, 3 weeks after culture in alginate. The left graphs demonstrate the amount of matrix components per construct, whereas for the right graphs matrix
production is normalized to the initially seeded primary ACs. A control condition—containing similar amounts of bACs (0.8106 nc/ml) without
supplementation of hMSCs—was evaluated to determine the additional effect of hMSCs (3.2106 nc/ml) on bACs in co-cultures (dotted line). ,  or 
indicates p-values smaller than 0.05, 0.01 or 0.001 respectively compared to the control condition. Data are shown as mean ± SD. For statistical evaluation, a
mixed model was used followed by a Bonferroni’s post-hoc comparisons test. hAMSC = human Adipose-tissue-derived Mesenchymal Stem Cell (n = 3
experiments with 3 independent donors); hBMSC = human Bone-marrow-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors);
bAC = bovine Articular Chondrocyte (n = 3 experiments with 3 pools of donors). Per experiment, 3 samples were used for analyses.
https://doi.org/10.1371/journal.pone.0190744.g002
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2B) The production of collagen was enhanced in co-cultures of both hAMSC/bACs and hBMSC/
bACs compared to single-cell-type populations (hAMSC/bACs p = 0.002; hBMSC/bACs p<
0.001). (Fig 2C) Normalization of the total GAG content to the initially seeded primary ACs
revealed even more distinct differences between co-cultures and single-cell-type populations:
hBMSC/bACs produced significantly more GAG compared to bACs only and co-cultures of
hAMSC/bACs (both p<0.001); collagen production was significantly enhanced in both co-cul-
tures (hAMSC/bACs p = 0.013; hBMSC/bACs p<0.001). (Fig 2B and 2C) Similar results were
obtained after 5 weeks of culture. (Data not shown) These results demonstrate that co-cultures of
hMSCs and bACs improve cartilage formation in vitro, depending on the hMSC-source used
(hBMSC hAMSC).
In vivo outcomes. Cell-free alginate constructs (controls; n = 4) and alginate constructs
containing hBMSC/bACs, hAMSC/bACs or hBMSC, hAMSC or bAC only, were generated
and immediately implanted subcutaneously in athymic mice. After 8 weeks, all but 5 (n = 3
hAMSC, n = 2 hBMSC) of the 40 constructs could be identified and harvested. Unfortunately
however, the remaining hMSC-constructs (either hAMSCs or hBMSCs) and cell-free alginate
constructs were lost during the embedding process. Constructs containing bACs or hBMSC/
bACs resembled cartilage tissue in both color and texture, while the appearance of constructs
containing hAMSC/bACs was particularly donor-dependent. (Fig 3) None of the constructs
had mineralized or ossified. Also, vascularization within the construct, was never observed.
Cells were more heterogeneously distributed in constructs containing either hAMSC/bACs or
hBMSC/bACs compared to bACs only. Collagen type II was abundantly present in constructs
containing bAC or hBMSC/bACs. Again, hAMSC/bACs contained collagen type II in a
donor-dependent manner. (Fig 3) A Safranin-O staining displayed similar results. (S2 Fig)
Fig 3. Macroscopic appearance and immunohistochemical analyses of constructs containing hMSCs and/or bACs, 8 weeks after subcutaneous
implantation in mice. Macroscopic appearance (top row) of cartilage constructs, as well as a collagen type II immunohistochemical staining (bottom rows), 8
weeks after subcutaneous implantation. hAMSC = human Adipose-tissue-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors);
hBMSC = human Bone-marrow-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors); bAC = bovine Articular Chondrocyte
(n = 3 experiments with 3 pools of donors). Per experiment, 2 samples were used for analyses.
https://doi.org/10.1371/journal.pone.0190744.g003
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In vivo, DNA- and GAG-content were not detected in cell-free alginate constructs. (Data
not shown) hAMSC/bACs and hBMSC/bACs contained similar quantities of cartilage matrix
as constructs containing bACs only. Moreover GAG formation in co-cultures was indepen-
dent of the origin of the hMSC-source used (p = 0.916). (Fig 4A) Collagen production demon-
strated a similar trend, again without statistical significant differences between hAMSC/bACs
and hBMSC/bACs (p = 1.000). (Fig 4B) Normalization of the data to their initially seeded pri-
mary ACs revealed more distinct differences between mixed-cell-type and single-cell-type
populations: hAMSC/bACs and hBMSC/bACs produced significantly more GAG and collagen
per initially seeded primary ACs compared to bACs (hAMSC/bACs p<0.01; hBMSC/bACs
p<0.05). (Fig 4) After subcutaneous implantation, the elastic modulus was highest in con-
structs containing hAMSC/bACs and hBMSC/bACs, albeit this did not reach statistical sig-
nificance due to the large variation between samples. (Fig 4C) These results confirm our in-
vitro results by showing that co-cultures of hMSCs and bACs improve cartilage formation.
Fig 4. Cartilage matrix formation in constructs containing hMSCs and/or bACs, 8 weeks after subcutaneous implantation in mice. Biochemical (GAG
(A) and collagen (B) content) and biomechanical evaluation (C), 8 weeks after subcutaneous implantation. The left graphs in A and B, demonstrate the
amount of matrix components per construct, whereas for the right graphs matrix production is normalized to the initially seeded primary ACs. A control
condition—containing similar amounts of bACs (0.8106 nc /ml) without supplementation of hMSCs—was evaluated to determine the additional effect of
hMSCs (3.2106 nc /ml) on bACs in co-cultures (dotted line). ,  or  indicates p-values smaller than 0.05, 0.01 or 0.001 respectively compared to the
control condition. Data are shown as box-whisker plots. For statistical evaluation, a Kruskal-Wallis followed by the Mann-Whitney-U test was used followed
by a Bonferroni’s post-hoc comparisons test. hAMSC = human Adipose-tissue-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent
donors); hBMSC = human Bone-marrow-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors); bAC = bovine Articular
Chondrocyte (n = 3 experiments with 3 pools of donors). Per experiment, 2 samples were used for analyses.
https://doi.org/10.1371/journal.pone.0190744.g004
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However, in vivo this phenomenon seems independent of the hMSC-source used, although
large donor variation is observed.
Differentiation versus chondroinduction
Using a xenogeneic in-vitro culture system enabled us to determine the contribution of each
individual cell type (i.e. hBMSCs, hBMSCs or bACs) to cartilage matrix production using spe-
cies-specific gene-expression analyses.
First, GAPDH-gene expression was analyzed after 5 weeks of in-vitro culture. hAMSC/bACs
and hBMSC/bACs contained cells from both bovine (AC) and human (AMSC or BMSC) ori-
gin. (Fig 5A) Then, chondrogenic gene expression was evaluated by the ACAN and COL2A1
genes. In a growth-factor-free environment, hAMSCs and hBMSCs hardly expressed hsACAN
and hsCOL2A1. Besides, chondrogenic genes were hardly expressed in hAMSC/bACs or
hBMSC/bACs either. Conversely, hAMSC/bACs or hBMSC/bACs—containing solely 20%
bovine articular chondrocytes—expressed as much or even higher levels of bsACAN compared
to 100% bACs (hAMSC/bACs vs bACs p>0.05; hBMSC/bACs vs bACs p<0.001). hAMSC/
bACs and hBMSC/bACs expressed COL2A1, although gene-expression of hsCOL2A1 was neg-
ligible. This means that the COL2A1 expressed was from bovine origin. (Fig 5B) These data
indicate that the formed cartilage matrix was from bAC-origin, which suggests a more trophic
role for hMSCs herein.
Cellular interactions
To further understand the complex cellular interaction between hMSCs and bACs, cells were
encapsulated in separate alginate constructs and co-cultured in a Transwell1 system as well as
in medium conditioned by the other cell type. (Figs 6A and 7A) In addition cell combination
were also cultured in pellets, allowing direct cell-cell contact.
Alginate constructs containing solely bACs, hAMSCs or hBMSCs cultured in ‘basic
medium’ maintained their DNA content over the 3 weeks of culture. Exposure to paracrine
factors of bAC via Transwell1 system or bAC-conditioned medium, did not alter the amount
of DNA in alginate constructs seeded with either hAMSCs or hBMSCs. (Fig 6B) The presence
of factors secreted by hMSC significantly increased the total amount of DNA in constructs
containing bACs (p<0.01). This effect was independent on the origin of the hMSCs (i.e.
hAMSCs, hBMSCs) and co-culture system used (i.e. Transwell1 system, hMSC-conditioned
medium). (Fig 7B) This suggests MSC have paracrine effects on chondrocytes.
Alginate constructs containing hAMSCs or hBMSCs, formed very little GAG after 3 weeks
of culture. GAG-production remained similarly low when hMSC-constructs were cultured in
the presence of paracrine factors of bAC via Transwell1 system or bAC-conditioned medium.
(Fig 6B) The production of GAG was higher in constructs containing bACs. Exposure to para-
crine factors of hMSC significantly increased GAG-production, irrespective to the hMSC-
source used (i.e. hAMSCs, hBMSCs, p<0.01). Since the amount of DNA was also enhanced in
these constructs, GAG content was adjusted to the amount of DNA, still showing pronounced
differences. GAG formation was significantly increased in Transwell1 system compared to
constructs cultured with bAC-conditioned medium (p<0.01). (Fig 7B) Similar trends were
observed at COL2A1 gene-expression level. (Fig 7D) This provides further indications that the
effect of the combination of hMSCs and bACs on chondrogenesis is due to paracrine effect of
hMSCs on chondrocytes.
Based on previous results, we further wanted to evaluate signs of hypertrophy in these con-
structs, since hypertrophic differentiation is an unwanted phenomenon in cartilage regenera-
tion. bACs cultured in ‘basic medium’ expressed hardly any COL10 after 3 weeks of culture. In
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addition, when bACs were exposed to paracrine factors of hMSC either via Transwell1 system
or hMSC-conditioned medium, COL10-gene-expression was upregulated and significantly
increased in constructs exposed to paracrine factors of hAMSCs (Transwell1 system
Fig 5. Gene-expression analysis, 5 weeks after in vitro culture. Data are shown as mean CT-values ± SD of housekeeping genes (A) and average
relative gene-expression of chondrogenic genes (B). nd = not detected (ct-value> 35.00); hsGAPDH = human-specific GAPDH; bsGAPDH = bovine-
specific GAPDH; hsACAN = human-specific ACAN; bsACAN = bovine-specific ACAN; hsCOL2A1= human-specific COL2A1; hAMSC = human
Adipose-tissue-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors); hBMSC = human Bone-marrow-derived Mesenchymal
Stem Cell (n = 3 experiments with 3 independent donors); bAC = bovine Articular Chondrocyte (n = 3 experiments with 3 pools of donors). Per
experiment, 3 samples were used for analyses.
https://doi.org/10.1371/journal.pone.0190744.g005
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p = 0.004; hAMSC-conditioned medium p = 0.028). Although COL10-gene-expression was
slightly upregulated in constructs exposed to paracrine factors of hBMSC, no significant differ-
ences could be observed in comparison with constructs cultured in ‘basic medium’ (both
Transwell1 system and hBMSC-conditioned medium p>0.05). (Fig 7D)
This indicates that hMSCs have the ability to improve cartilage matrix formation in co-cul-
ture, by improving bAC-proliferation capacity as well as increasing bAC-GAG-production.
Moreover, when exposed to paracrine factors of hBMSC, hypertrophic differentiation was not
significantly enhanced compared to untreated bACs. In pellet co-culture, matrix production
was similarly produced as in 3D-alginate constructs, meaning that direct cell-cell contact is not
required for co-cultures of hMSCs and bACs. (Fig 7C)
Fig 6. Paracrine effect of bACs on hAMSCs and hBMSCs. (A) Schematic overview. In purple: hMSCs; in green: bACs. (B) The DNA and GAG content of hAMSCs
and hBMSCs in the presence of paracrine factors of bACs via Transwell1 system or bAC-conditioned medium. The DNA content after 3 weeks of culture was
compared to the initial DNA content prior to cell-culture (dotted line). ,  or  indicates p-values smaller than 0.05, 0.01 or 0.001 respectively compared to the
amount of DNA prior to cell culture. Data are shown as box-whisker plots of 6 samples of one experiment. For statistical evaluation, a Kruskal-Wallis followed by the
Mann-Whitney-U test was use followed by a Bonferroni’s post-hoc comparisons test. TW = Transwell; CM = Conditioned Medium; hAMSC = human Adipose-tissue-
derived Mesenchymal Stem Cell; hBMSC = human Bone-marrow-derived Mesenchymal Stem Cell; bAC = bovine Articular Chondrocyte.
https://doi.org/10.1371/journal.pone.0190744.g006
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Discussion
Combining chondrocytes and MSCs holds great promise for cell-based cartilage repair as it
reduces the required number of chondrocytes and diminishes many disadvantages of individ-
ually used cell types leading to enhanced cartilage matrix formation with low hypertrophic dif-
ferentiation. In line with former research, hAMSC/bACs and hBMSC/bACs produced similar
or even improved quantities of cartilage matrix components as constructs containing bACs
only, both in vitro and in vivo. Moreover, hypertrophic gene expression (COL10) was not
affected by hBMSCs, but slightly enhanced by hAMSCs. However, constructs containing either
hAMSC/bACs or hBMSC/bACs appeared stable and did not calcify in vivo. This suggests that
80% of bACs can be replaced by either hAMSCs or hBMSCs without influencing cartilage
matrix production nor stability. Therefore, mixed-cell-cultures of MSCs and chondrocytes
could be very valuable for cell-based cartilage repair, as appropriate numbers of cells are more
easily acquired from bone-marrow aspirates or adipose tissue than from cartilage biopsies.
The cellular mechanism responsible for enhanced cartilage production in co-culture is
however still debated. Numerous cellular communication pathways have been hypothesized in
Fig 7. Paracrine effect of hAMSCs and hBMSCs on bACs. (A) Schematic overview. In purple: hMSCs; in green: bACs. (B) The DNA and GAG content of bACs in the
presence of paracrine factors of hMSCs via Transwell1 system or hMSC-conditioned medium. The DNA content after 3 weeks of culture was compared to the initial
DNA content prior to cell-culture (dotted line). (C) Co-culture in alginate constructs and pellet culture, allowing direct cell-cell contact. (D) Relative gene-expression
analysis, 3 weeks after culture in alginate. ,  or  indicates p-values smaller than 0.05, 0.01 or 0.001 respectively compared to the amount of DNA prior to cell
culture. # indicates significant differences from all conditions (p<0.01). Data are shown as box-whisker plots of 6 samples of one experiment. For statistical evaluation,
a Kruskal-Wallis followed by the Mann-Whitney-U test was use followed by a Bonferroni’s post-hoc comparisons test. TW = Transwell; CM = Conditioned Medium;
hAMSC = human Adipose-tissue-derived Mesenchymal Stem Cell; hBMSC = human Bone-marrow-derived Mesenchymal Stem Cell; bAC = bovine Articular
Chondrocyte.
https://doi.org/10.1371/journal.pone.0190744.g007
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order to explain the beneficial effect in co-cultures [53]. We found no evidence that cartilage
formation was the consequence of chondrogenic lineage differentiation of hMSCs, as stated by
others [41, 49, 54–62]. In contrast, cartilage matrix clearly originated from bACs, which sug-
gests a predominantly trophic role for hMSCs in these constructs: both hAMSCs and hBMSCs
improved bAC-proliferation as well as bAC-GAG-formation. This confirms previous studies
were the co-culture effect has been ascribed to ACs, whose cartilage-forming capacity and pro-
liferation activity appears to enhance in the presence of MSCs. [40, 50, 63–68] The trophic and
paracrine function of MSCs herein appeared essential rather than MSCs actively undergoing
chondrogenic differentiation. We show that this is a general feature that applies to both
AMSCs and BMSCs.
To date, only three studies have compared the trophic effect of several MSC-sources—such
as AMSCs and BMSCs—on ACs in co-culture. [40–42] Unfortunately, these studies demon-
strate conflicting outcomes and have never translated to animal research. Therefore, to our
knowledge, we are the first to systematically compare the cartilage forming capacity of either
hAMSC/bACs and hBMSC/bACs in vitro and in vivo. In vitro, hBMSC/bACs contained signifi-
cantly more cartilage matrix components than hAMSC/bACs. Cartilage formation after 8
weeks of subcutaneous implantation was, however, not different in constructs containing
hAMSC/bACs and hBMSC/bACs, although large donor variations were observed, in particular
in hAMSC/bACs. Our results support a general trophic or immunomodulatory role for
hAMSCs and hBMSCs on bACs in co-culture, as stated by Wu [40] and Maumus et al [42].
Although both cell sources share comparable immunomodulatory modalities, they do not nec-
essarily behave the same. In monocultures there are clear differences observed between
hAMSCs and hBMSCs. For instance, they possess distinctive proliferation capacities and a dis-
similar potential to chondrogenically differentiate. [2] Moreover, both cell sources secrete dif-
ferent subsets of paracrine factors: compared to hBMSCs, hAMSCs secrete significantly more
VEGF-D [69], IGF-1 [69, 70], IL-8 [69] and IL-6 [69, 71], and significantly less SDF-1 [72] and
TFGβ1 [72]. In co-cultures, differences between hMSC-cell sources appear less clear. Acharya
et al. demonstrated enhanced chondrocyte proliferation capacity and improved GAG forma-
tion in pellets containing hBMSC/bACs compared to hAMSC/bACs. [41] Besides, 3 indepen-
dent co-culture studies using AMSCs only showed limited or decreased effects of MSCs on
chondrogenesis. [37–39] Such effect was hardly seen in co-culture studies using BMSCs only,
which may propose that, compared to BMSCs, AMSCs seem less efficient in co-culture,
Although we could not find a general beneficial effect of hBMSCs in co-cultures compared to
hAMSCs in vitro and in vivo, we did show that in vitro, hBMSC/bACs outperformed hAMSC/
bACs and hypertrophic gene expression was lower in hBMSC/bACs. True dissimilarities
between hAMSCs and hBMSCs in co-culture are unfortunately hard to expose, as hMSC-cul-
tures are highly heterogeneous and distinct population subsets will probably interfere with the
reciprocal communication pathways in co-culture. Therefore, the purification of distinct sub-
sets of hMSCs might enhance the particular capability of hAMSCs and hBMSCs in co-culture
by eliminating interfering cells with limited potential, or even cells with inhibitory activity.
Future research still needs to clarify whether the trophic role of MSCs in co-culture is truly a
general MSC-characteristic produced by a distinct subset of the MSC-population or dependent
on the original origin of the MSCs.
Our data and that of others emphasize the importance of paracrine signaling pathways in
co-culture comparatively to juxtacrine or gap-junctional signaling. Although the importance
of direct cell-cell contact is still unclear in literature [63], such signaling pathways remained
less important in our study, since alginate hydrogel impedes direct cell-cell contact and in pel-
let culture no beneficial effect of direct cell-cell contact was observed. On the contrary, bACs
produced less cartilage matrix in Transwell1 system with hMSCs and the amount of cartilage
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matrix was further reduced in hMSC-conditioned medium. Although direct cell-cell contact
seems less significant than paracrine signaling, it seems correspondingly important to secure a
certain cell-cell distance for optimal cell communication.
Furthermore, for optimal cell communication and subsequent cartilage regeneration, an
optimal cell density and ratio of MSCs to ACs is imperative. Additionally, for cell-based carti-
lage repair, it would be ideal to only use low numbers of primary chondrocytes. Although Pue-
lacher et al already recommended cell densities greater than 20x106 cells per milliliter [73], we
could not increase the cell seeding density over 4x106 cells per milliliter, as the size of our
experimental set-up did not enable higher densities. Additionally, we have replaced 80% of the
bACs by hMSCs (at a 4:1 ratio), as described previously. [40, 50] However, no consensus on
optimal co-culture ratios is yet available. Future research needs to clarify if we could increase
cell density while further reduce the number of primary chondrocytes (increase the MSC-
chondrocyte-ratio) without inhibiting cartilage matrix production and stability.
The species mismatch limited the translation of presented basic research to clinical applica-
tion. However, the species mismatch was chosen to be able to discriminate between the role of
the different cell types. We do not expect huge differences in fully human co-culture models,
as both xenogeneic and autologous co-culture models have resulted in comparable outcomes,
indicating that in both models comparable mechanisms are likely operational. [50] Our results
confirmed previously published results of hMSCs combined with xenogeneic chondrocytes.
[50, 74–76] Therefore, it appears to be an excellent model to study cell-specific contributions
to tissue formation.
In conclusion, this study demonstrates that 80% of chondrocytes can be replaced by either
hAMSCs or hBMSCs without influencing cartilage matrix production nor stability. Besides,
our results support a general trophic role for hAMSCs and hBMSCs on chondrocytes in co-
culture that does not need direct cell-cell contact. These data provide information that can be
used to further optimize cell-based cartilage repair.
Supporting information
S1 Fig. Cartilage matrix formation in constructs containing hMSCs and/or bACs, 5 weeks
after in-vitro culture. (A) The DNA content of none of the constructs had changed compared
to their initial DNA content prior to cell-culture (dotted line). Biochemical evaluation of the
GAG (B) and collagen (C) content, 5 weeks after culture in alginate. The left graphs demon-
strate the amount of matrix components per construct, whereas for the right graphs matrix
production is normalized to the initially seeded primary ACs. A control condition—contain-
ing similar amounts of bACs (0.8106 nc/ml) without supplementation of hMSCs—was evalu-
ated to determine the additional effect of hMSCs (3.2106 nc/ml) on bACs in co-cultures
(dotted line).  indicates a p-value smaller than 0.001 compared to the control condition.
Data are shown as mean ± SD. For statistical evaluation, a mixed model was used followed by
a Bonferroni’s post-hoc comparisons test. hAMSC = human Adipose-tissue-derived Mesen-
chymal Stem Cell (n = 3 experiments with 3 independent donors); hBMSC = human Bone-
marrow-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors);
bAC = bovine Articular Chondrocyte (n = 3 experiments with 3 pools of donors). Per experi-
ment, 3 samples were used for analyses.
(TIF)
S2 Fig. Macroscopic appearance and histochemical analyses of constructs containing
hMSCs and/or bACs, 8 weeks after subcutaneous implantation in mice. Macroscopic
appearance (top row) of cartilage constructs, as well as a Safranin-O histochemical staining
(bottom rows), 8 weeks after subcutaneous implantation. hAMSC = human Adipose-tissue-
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derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent donors); hBMSC =
human Bone-marrow-derived Mesenchymal Stem Cell (n = 3 experiments with 3 independent
donors); bAC = bovine Articular Chondrocyte (n = 3 experiments with 3 pools of donors). Per
experiment, 2 samples were used for analyses.
(TIF)
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